Research Topics
| T J HoergerSummaryAffiliation: RTI International Country: USA Publications
| Collaborators
|
Detail Information
Publications
Cost-effectiveness of hepatitis B vaccination in adults with diagnosed diabetesThomas J Hoerger
RTI International, Research Triangle Park, NC, USA
Diabetes Care 36:63-9. 2013..Partly based on these results, the Advisory Committee on Immunization Practices recently recommended hepatitis B vaccination for people 20-59 years of age with diagnosed diabetes...- Cost-effectiveness of screening for microalbuminuria among African AmericansThomas J Hoerger
RTI International, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA
J Am Soc Nephrol 23:2035-41. 2012..In summary, these models suggest that screening African Americans for microalbuminuria at either 5- or 10-year intervals is highly cost-effective... 
Is glycemic control improving in U.S. adults?Thomas J Hoerger
RTI UNC Center of Excellence in Health Promotion Economics, RTI International, 3040 Cornwallis Rd, P O Box 12194, Research Triangle Park, NC 27709, USA
Diabetes Care 31:81-6. 2008..The purpose of this study was to examine whether glycemic control has improved in recent years among individuals with diagnosed diabetes...- The impact of diabetes and associated cardiometabolic risk factors on members: strategies for optimizing outcomesThomas J Hoerger
Research Triangle Institute International, USA
J Manag Care Pharm 14:S2-14; quiz 15-6. 2008.... 
Using costs in cost-effectiveness models for chronic diseases: lessons from diabetesThomas J Hoerger
RTI UNC Center of Excellence in Health Promotion Economics, RTI International, Research Triangle Park, North Carolina 27709, USA
Med Care 47:S21-7. 2009..Cost-effectiveness models for chronic diseases frequently require simulating the development of disease complications over a long period. Model development often focuses on disease progression, with less attention devoted to costs...- Improvements in risk factor control among persons with diabetes in the United States: evidence and implications for remaining life expectancyThomas J Hoerger
RTI International, Research Triangle Park, NC 27709, USA
Diabetes Res Clin Pract 86:225-32. 2009..S. adults with diagnosed diabetes between 1988-1994 and 2005-2006. We then project the impact of these changes on life expectancy and diabetes-related complications... - A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screeningThomas J Hoerger
RTI International, Research Triangle Park, NC 27709, USA
Am J Kidney Dis 55:463-73. 2010..Microalbuminuria screening may detect chronic kidney disease in its early stages, allowing for treatment that delays or prevents disease progression. The cost-effectiveness of microalbuminuria screening has not been determined... - A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequencesThomas J Hoerger
RTI International, Research Triangle Park, NC 27709, USA
Am J Kidney Dis 55:452-62. 2010..A cost-effectiveness model that accurately represents disease progression, outcomes, and associated costs is necessary to evaluate the cost-effectiveness of interventions for chronic kidney disease (CKD)... - Cost-effectiveness of bariatric surgery for severely obese adults with diabetesThomas J Hoerger
RTI UNC Center of Excellence in Health Promotion Economics, RTI International, Research Triangle Park, North Carolina, USA
Diabetes Care 33:1933-9. 2010..To analyze the cost-effectiveness of bariatric surgery in severely obese (BMI >or=35 kg/m(2)) adults who have diabetes, using a validated diabetes cost-effectiveness model... - A cost-benefit analysis of lipid standardization in the United StatesThomas J Hoerger
RTI International, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709, USA
Prev Chronic Dis 8:A136. 2011..The objective of this study was to estimate the benefits (ie, the value of reductions in heart disease deaths) and costs attributable to these lipid standardization programs... - Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adultsThomas J Hoerger
Center of Excellence in Health Promotion Economics, RTI International, 3040 Cornwallis Rd, P O Box 12194, Research Triangle Park, NC 27709, USA
Diabetes Care 30:2874-9. 2007..To estimate the cost-effectiveness of screening overweight and obese individuals for pre-diabetes and then modifying their lifestyle based on the Diabetes Prevention Program (DPP)... - Medicare's demonstration of competitive bidding for clinical laboratory services: what it means for clinical laboratoriesT J Hoerger
Research Triangle Institute, Research Triangle Park, NC 27709 12194, USA
Clin Chem 44:1728-34. 1998..We close with some brief comments on how to succeed in competitive bidding for Medicare services... - Cost effectiveness of pramipexole in Parkinson's disease in the UST J Hoerger
Center for Economics Research, Research Triangle Institute, Research Triangle Park, North Carolina, USA
Pharmacoeconomics 14:541-57. 1998..The aim of this study was to estimate the costs and cost effectiveness (cost utility) of pramipexole compared with baseline treatment in patients with early and advanced PD... - Medicare beneficiary satisfaction with durable medical equipment suppliersT J Hoerger
Health Care Financ Rev 23:123-36. 2001..Results of our analysis can be used as baseline estimates in evaluating CMS initiatives to reduce Medicare payments for DMEPOS... - Screening for type 2 diabetes mellitus: a cost-effectiveness analysisThomas J Hoerger
RTI International, Research Triangle Park, North Carolina 27709, USA
Ann Intern Med 140:689-99. 2004..No randomized, controlled trial of screening for diabetes has been conducted. In the absence of direct evidence, cost-effectiveness models may provide guidance about preferred screening strategies... - Optimal allocation of resources across four interventions for type 2 diabetesStephanie R Earnshaw
RTI Health Solutions, RTI, 3040 Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709, USA
Med Decis Making 22:S80-91. 2002..CONCLUSIONS: A resource allocation model identifies trade-offs involved when imposing budget and equity constraints on care for individuals with newly diagnosed diabetes... - Individual and aggregate years-of-life-lost associated with overweight and obesityEric A Finkelstein
RTI International, Research Triangle Park, North Carolina, USA
Obesity (Silver Spring) 18:333-9. 2010..Unless something is done to reduce the rising prevalence of those with BMIs >35, or to mitigate the impact of obesity or its correlates on YLLs, expected life expectancy for US adults may decrease in the future... - Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatmentsDavid B Rein
Research Triangle Institute International, Research Triangle Park, North Carolina, USA
Arch Ophthalmol 127:533-40. 2009..To forecast age-related macular degeneration (AMD) and its consequences in the United States through the year 2050 with different treatment scenarios... - The cost-effectiveness of routine office-based identification and subsequent medical treatment of primary open-angle glaucoma in the United StatesDavid B Rein
RTI International, Research Triangle Park, North Carolina
Ophthalmology 116:823-32. 2009..To estimate the incremental cost-effectiveness of routine glaucoma assessment and treatment under current eye care visit and treatment patterns and different levels of treatment effectiveness (from randomized trials)... - Comparing cost-of-illness estimates from alternative approaches: an application to diabetesAmanda A Honeycutt
RTI International and RTI UNC Center of Excellence in Health Promotion Economics, 118 Beaufain Street, Charleston, SC 29401, USA
Health Serv Res 44:303-20. 2009..To compare disease cost estimates from two commonly used approaches... - The economic burden of major adult visual disorders in the United StatesDavid B Rein
RTI International, Research Triangle Park, NC, USA
Arch Ophthalmol 124:1754-60. 2006.... - Cost-effectiveness of osteoporosis screening and treatment with hormone replacement therapy, raloxifene, or alendronateLee R Mobley
Division for Health Services and Social Policy Research, RTI International Research Triangle Institute, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA
Med Decis Making 26:194-206. 2006..The authors conclude that screening and treating with alendronate are more cost-effective than screening and treating with raloxifene or HRT. Relative to an NST strategy, alendronate has a fairly good cost-effectiveness ratio... - Cost-effectiveness of routine childhood vaccination for hepatitis A in the United StatesDavid B Rein
RTI International, 2951 Flowers Rd, Suite 119, Atlanta, GA 30306, USA
Pediatrics 119:e12-21. 2007..We evaluated the economic impact of hepatitis A vaccination of all US children ages 12 to 23 months as compared with no vaccination and with current implementation of the preexisting (issued in 1999), regional policy... - Cost-effectiveness of vitamin therapy for age-related macular degenerationDavid B Rein
RTI International, Research Triangle Park, North Carolina, USA
Ophthalmology 114:1319-26. 2007..To determine the cost-effectiveness of vitamin therapy (antioxidants plus zinc) for all indicated patients diagnosed with age-related macular degeneration (AMD)... - Technical appendix: cost-effectiveness of vitamin therapy for age-related macular degenerationDavid B Rein
RTI International, Research Triangle Park, North Carolina 30341, USA
Ophthalmology 114:e13-20. 2007 - A dynamic Markov model for forecasting diabetes prevalence in the United States through 2050Amanda A Honeycutt
Research Triangle Institute, USA
Health Care Manag Sci 6:155-64. 2003..The projected number of people with diagnosed diabetes rises from 12.0 million in 2000 to 39.0 million in 2050, implying an increase in diagnosed diabetes prevalence from 4.4% in 2000 to 9.7% in 2050... - Use of econometric models to estimate expenditure sharesJustin G Trogdon
RTI International, 3040 Cornwallis Rd, PO Box 12194, Research Triangle Park, NC 27709 2194, USA
Health Serv Res 43:1442-52. 2008..To investigate the use of regression models to calculate disease-specific shares of medical expenditures... - High-risk individuals' willingness to pay for diabetes risk-reduction programsF Reed Johnson
RTI-UNC Center for Excellence in Health Promotion Economics, RTI International, 3040 Cornwallis Road, P.O. Box 12194, Research Triangle Park, NC 27709, USA
Diabetes Care 29:1351-6. 2006..Our results also offer insights for designing risk-reduction programs that appeal to potential participants... - The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose toleranceWilliam H Herman
University of Michigan Health System, Ann Arbor, Michigan, USA
Ann Intern Med 142:323-32. 2005..LIMITATIONS: Simulation results depend on the accuracy of the underlying assumptions, including participant adherence. CONCLUSIONS: Health policy should promote diabetes prevention in high-risk individuals... - An evaluation of cost sharing to finance a diet and physical activity intervention to prevent diabetesRonald T Ackermann
Department of Medicine, Indiana University School of Medicine, 250 University Blvd, Suite 122, Indianapolis, IN 46202, USA
Diabetes Care 29:1237-41. 2006..We explored whether this intervention could be offered in a way that allows return on investment for private health insurers while remaining attractive for consumers, employers, and Medicare... - Managing people at high risk for diabetesWilliam H Herman
Ann Intern Med 144:66-7; author reply 67-8. 2006